Clearwater Paper: Asset Value Provides Downside Protection Despite Near-Term Earnings Headwinds

A conservative recovery framework applied to Q1 2026 results implies an adjusted equity liquidation value of $376 million, suggesting downside protection, while Q1 EBITDA finished slightly above expectations despite weather disruptions. Margin support is expected to build gradually from lower industry supply, falling FBB imports, announced price increases, and improving utilization rates. Offsetting negatives include uncertainty around Augusta integration and insurance claims tied to the acquisition, ongoing commodity cost inflation, and the lack of full-year EBITDA guidance, limiting visibility.

Analysis

The important takeaway is not the liquidation math by itself; it is that the equity now has a visible downside anchor while the operating model still has upside optionality if pricing and utilization stay on the current path. In a fixed-cost paper/board business, incremental price and volume recovery can translate into disproportionate margin upside once plants are better loaded, so the stock’s next rerating will be driven more by sequential EBITDA inflection than by headline NAV.

Competitive dynamics look better for the larger domestic players than for import-dependent converters. If folding boxboard imports keep declining and announced price increases stick, smaller buyers will have less ability to arbitrage offshore supply, which should support domestic pricing discipline and compress customer margins before it shows up in producer results. The second-order benefit is that better industry utilization can force weaker competitors to follow price rather than chase volume, improving the odds that gross margin expands into 2H26.

The main risks are execution and timing: Augusta integration can absorb near-term cash and management attention, while commodity cost inflation can lag the price actions and erase the near-term gross margin benefit. The market is also likely overvaluing the liquidation floor as if it were a cash takeout price; it is only meaningful if the asset base can be monetized without further deterioration. The thesis breaks if Q2/Q3 EBITDA fails to improve sequentially, if price increases do not flow through to realized netbacks, or if insurance recoveries come in below expectations and remove a potential balance-sheet catalyst.

Key Decisions for Investors

• For accounts able to trade GPK, buy on weakness or use a 3-6 month call spread into the next earnings update; the setup is favorable if sequential EBITDA improves and management refrains from sounding more cautious on pricing. Target a 15-20% rerating over 1-3 months, but cut if margin improvement does not show up by the next print.
• Pair trade: long GPK / short IP over 1-3 months as a cleaner expression of domestic board pricing strength versus broader paper exposure. The spread works if lower imports and utilization drive price discipline, and it should be reduced if industry pricing rolls over or if GPK’s integration costs surprise higher.
• Do not short the name solely on the basis of near-term uncertainty; wait for a failed price increase, a sequential EBITDA miss, or materially worse insurance-clamability before betting against the downside floor. The first true bearish trigger would be a guidance cut or evidence that commodity inflation is outrunning realized pricing.
• Set an alert for any commentary on Augusta integration or insurance claims. Positive resolution there would convert the current story from a balance-sheet support case into an earnings recovery case; negative resolution would likely cap the multiple even if operating trends improve.